Napabucasin is another recently characterized orally bioavailable small-molecule STAT3 inhibitor capable of inducing cell cycle arrest, apoptosis, and the reduction of markers of stemness, leading to improved survival in an orthotopic murine glioma model [242,243]. This evidence concerns the gene STAT3 and glioma.